[Routine practice data collection for brexucabtagene autoleucel: Review of the study protocol (Version 2.0) and statistical analysis plan (Version 2.0) – Third Addendum to Commission A21-130]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005098
Original Title: Anwendungsbegleitende Datenerhebung zu Brexucabtagen Atoleucel: Prüfung des Studienprotokolls (Version 2.0) und des statistischen Analyseplans (Version 2.0) 3. Addendum zum Projekt A21-130
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Lymphoma, Mantle-Cell
  • Antigens, CD19
  • Immunotherapy, Adoptive
  • Receptors, Chimeric Antigen
  • Antineoplastic Agents, Immunological
  • Registries
  • Product Surveillance, Postmarketing
  • Brexucabtagene Autoleucel
  • Lymphoma – Mantle Cell
  • Registries
  • Benefit Assessment
  • Research Design
  • Peer Review – Research
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: <p>Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.